Memic Announces Completion of 1st Patient Cases Using Hominis Surgical System in Laparoscopic-Assisted Transvaginal Benign Gynecological Procedures

Memic Innovative Surgery Ltd. (Memic), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that HCA Florida Kendall Hospital and The Women’s Hospital at Jackson Memorial have successfully completed the first U.S. patient procedures using the company’s Hominis® Surgical System for robotic-assisted transvaginal hysterectomy.

Hominis Surgical System is the first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms, with shoulder, elbow, and wrist joints that provide high dexterity and unprecedented articulation.

“As a leading healthcare provider, it is important to continually identify and implement innovative and advanced technologies to provide an enhanced surgical experience and improved outcomes for patients. The significant benefits the Hominis System provides to both surgeons and patients made it clear that we should offer this advantageous technology,” said Ricardo E. Estape, MD, a practicing gynecologic oncologist at HCA Florida Kendall Hospital and director of HCA Healthcare’s Institute for Gynecologic Oncology. “We are proud to be the first healthcare system in the U.S. to perform a surgical procedure using the Hominis System. We now have technology that can help us do robotic surgery through a very novel vaginal approach.”

“With the completion of our first surgical procedure, we are excited to offer this new technology to a wide range of women who need to undergo benign gynecological procedures. This new robotic system leverages the transvaginal approach, which is known to offer less pain, lower infection rates, faster recovery, and virtually no visible scarring,” said Moises Lichtinger, MD, gynecologist at University of Miami Health System and The Women’s Hospital at Jackson Memorial.

The Hominis System is designed to replicate the motions and capabilities of a surgeon’s arms. Multiple instruments can be introduced into the body through a single portal and the unprecedented articulation offers optimal access and working angles. Hominis requires a much smaller footprint and costs significantly less than conventional robotic systems, making it possible for more hospitals and ambulatory surgery centers to acquire the system and offer more patients the benefits of less invasive robotic surgery. Hominis was granted de novo marketing authorization from the FDA in February 2021.

“It is very encouraging to see the first two U.S. commercial sites actively performing benign gynecological procedures using our Hominis System and we are grateful for their support,” said Dvir Cohen, president and chief executive officer of Memic. “Hominis is well positioned as a disruptive technology that will transform the way surgeons perform minimally invasive robotic-assisted procedures. We look forward to its continued use in the South Florida region and widespread adoption as we work to expand across the U.S. and worldwide.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy